期刊文献+

淫羊藿总黄酮对高脂血症大鼠血清脂联素水平的影响 被引量:6

Influence of Total Flavonoids of Epimedium on Serum Adiponectin in Hyperlipidemia Rats
下载PDF
导出
摘要 目的探索淫羊藿总黄酮对高脂血症大鼠血清脂联素水平的影响及其改善内皮细胞作用的可能机制。方法将SD大鼠随机分为高脂饮食组(26只)和对照组(9只)。高脂饮食组高脂饮食喂养12周后,随机分为模型组(8只)和低剂量淫羊藿总黄酮组(9只)、高剂量淫羊藿总黄酮组(9只),灌胃相应药物4周后检测各组大鼠血脂水平并观察主动脉病理变化,采用ELISA法检测脂联素水平。结果与模型组比较,高、低剂量淫羊藿总黄酮组甘油三酯、总胆固醇水平降低(P<0.05或0.01),可明显减轻高脂饮食所致主动脉内皮损伤、内膜断裂,改善平滑肌增生,血清脂联素水平显著升高(P<0.01),并且高剂量组脂联素水平比低剂量组升高明显(P<0.05)。结论淫羊藿总黄酮能够调节血脂,提高血清脂联素水平。这与淫羊藿总黄酮改善内皮功能、抗动脉粥样硬化有关。 Objective:To investigate the influence of total flavonoids of epimedium on adiponectin and the mechanism of its improvement of vascular endothelium in aorta of hyperlipidemia rats.Methods: 35 SD male rats were randomly divided into the high-fat diet group and the control group.After fat diet for 12 weeks,the high-fat diet group was randomly divided into the model group,the low-dose total favonoids of epimedium and the high-dose total favonoids of epimedium group.Being fed with corresponding drugs for 4 weeks,the serum lipid and the aortic pathological were detected.The level of adiponectin was tested by the ELISA method.Results: Compared with the model group,the TG level and the TC concentration were decreased in the low-dose and the high-dose total flavonoids of epimedium group.This drug could not only decrease the aortic imtimal injury and endometruim fracture,but also improve the smooth muscle proliferation and adiponictin level.Furthermore,the increase degree in the high dose group was more significant than that in the low dose group.Conclusion: The mechanism of that total flavonoids of epimedium can reduce the level of blood lipid,but increase the level of adiponectin could be related to its improve imtimal function and prevention of resistant with atherosclerosis.
出处 《中国中医急症》 2011年第1期93-95,共3页 Journal of Emergency in Traditional Chinese Medicine
关键词 淫羊藿总黄酮 高脂血症 脂联素 血管内皮 Total flavonoids of epimedium Hyperlipidemia Adiponectin Vascular endothelium
  • 相关文献

参考文献10

  • 1Xu H B,Huang Z Q.Vasorelaxant effects of icariin on isolated canine coronary artery[J].J Cardiovasc Pharmacol,2007,49(4):207-213.
  • 2裴志芳,夏珂,高琪乐,杨天伦.淫羊藿总黄酮对LPC诱导内皮细胞损伤的保护作用[J].中南药学,2009,7(6):410-412. 被引量:12
  • 3Hartvigsen K,Binder C J,Hansen L F,et al.A diet-induced hypercholesterolemic routine model to study atherogenesis without obesity and metabelic syndrome[J].Arterioscler Thromb Vasc Biol,2007,27(4):878-885.
  • 4陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 5Pal'tseva E M,Konstantinova S V,Severin S E.Novel biomarkers:adiponectin in contemporary diagnosis of cardiovascular diseases[J].Kardiologiia.2009; 49(10):65-74.
  • 6Wu X,Mahadev K,Fuchsel L,et al.Adiponectin suppresses I kappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells:role of cAMP and AMP kinase signaling[J].Am J Physlol Endocrinol Metab,2007,293(6):E1836-44.
  • 7Li R,Wang W Q,Zhang H,et al.Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity[J].Am J Physiol Endocrinol Metab,2007,293(6):E1703-1708.
  • 8Bray G A,Clearfield MB,Fintel D J,et al.Overweight and obesity:the pathogenesis of cardiometabolic ris[J].Clin Cornerstone,2009,9(4):30-42.
  • 9Li M R,Deng G,Yu Y R,et al.Effect of Adiponectin on endothelial dysfunction in obese rats[J].Sichuan Da Xue Xue Bao Yi Xue Ban,2009,40(4):612-614.
  • 10Ekmekci H,Ekmekci OB.The role of adiponectin in atherosclerosis and thrombosis[J].Clin Appl Thromb Hemost,2006,12(2):163-168.

二级参考文献16

  • 1王秋娟,潘志伟,岳攀,孔令义.淫羊藿总黄酮对动物实验性心肌缺血及血液流变学的影响[J].中草药,2007,38(7):1039-1042. 被引量:14
  • 2沈磊,张鸽,吴玉林.淫羊藿总黄酮对大鼠局灶性脑缺血的保护作用[J].中药新药与临床药理,2007,18(4):266-269. 被引量:9
  • 3John E. D, Julian P H, Ton J R. Endothelial Function and Dysfunction [J]. (Testing and Clinical Relevance) Circulation, 2007, 115 (3): 1285- 1295.
  • 4Vita JA, Keaney JF. Endothelial function: a barometer for cardiovascular risk [J]. Circulation, 2002, 106 (2): 640-642.
  • 5Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I. Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension [J]. J Hypertens, 2005, 23 (1): 7-17.
  • 6Tardif JC, Heinonen T, Orloff D, et al. Vascular biomarkers and surrogates in cardiovascular disease [J].Circulation, 2006, (113): 2936-2942.
  • 7Grafe M, Auch-Schwelk W, Hertel H, et al. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL [J]. Atherosclerosis, 1998, 137 (2): 87-95.
  • 8Watanabe T, Pakala R, Katagiri T, et al. Lysophosphatidyl- choline is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation [J]. J Cardiovasc Pharmacol, 2002, 39 (3): 449.
  • 9Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity [J]. N Engl J Med, 1989, 320 (14): 915- 924.
  • 10El-Remessy AB, Abou-Mohamed G, Caldwell RW, et al. High glucose-induced tyrosine nitration in endothelial cells role of eNOS uncoupling and aldose reductase activation [J]. Invest Ophthalmol Vis Sci, 2003, 44 (7): 3135-3143.

共引文献2795

同被引文献83

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部